NEW YORK, August 10, 2026, 08:04 EDT
- IonQ announced second-quarter revenue of $80.1 million and increased its 2026 guidance to a range of $280 million to $290 million.
- With first-half revenue reaching $144.7 million, the revised midpoint indicates second-half revenue of $140.3 million, representing a 3.1% decrease quarter-on-quarter.
- The stock ended Friday up 11.9% at $44.43. Early premarket indications on Monday pointed to a 1.5% decline.
IonQ’s higher outlook holds a subtler implication beyond its headline numbers. Revenue for the first half totaled $144.718 million. With the annual guidance midpoint at $285 million, the remaining $140.282 million is set for the second half.
This marks a 3.1% drop compared to the first half. Achieving the top of the guidance range would mean growth of just 0.4%. At the lower bound, this would translate to a 6.5% decrease. The next challenge is sustaining performance, rather than seeing faster gains.
The regular U.S. cash session had yet to begin at press time. IonQ closed on Friday at $44.43, rising 11.9% for the day and 21.9% for the week. Early trading at 8:00 a.m. ET indicated $43.77, a decrease of 1.5%.
The surge came after the company outperformed expectations on both revenue and adjusted earnings. The consensus numbers given below reflect pre-earnings projections from Barron’s and Investor’s Business Daily.
| Metric | Q2 2026 result | Comparison | Variance or context |
|---|---|---|---|
| Revenue | $80.05 million | $66.5 million consensus | Surpassed by 20.4% |
| Revenue growth | 287% | $20.69 million in Q2 2025 | Rose nearly fourfold |
| Adjusted EPS | $(0.33) | $(0.56) consensus | $0.23 higher |
| Adjusted EBITDA | $(120.3) million | $(95.6) million excluding SkyWater spending | $24.7 million gap |
| GAAP net loss | $(1.868) billion | — | Factored in $1.649 billion warrant fair-value loss |
The company also saw a more diversified revenue mix, with international accounting for around 50%, commercial at 60%, and multi-product comprising 25%. Overlap exists among these segments. Chief Operating Officer and Chief Financial Officer Inder Singh said the revenue base was “broadening in ways that reinforce its durability.” Remaining performance obligations hit $485 million, marking a 297% increase from a year earlier. IonQ Investors
The guidance bridge is narrower. These figures are based on revenue reported by the company and the past and present ranges.
| Guidance calculation | Result | Investor read-through |
|---|---|---|
| H1 reported revenue | $144.718 million | 50.8% of the revised midpoint |
| H2 revenue suggested by new midpoint | $140.282 million | 3.1% less than in the first half |
| H2 interval suggested by guidance | $135.282 million–$145.282 million | 6.5% lower to 0.4% higher compared with H1 |
| Q2 outperformance versus previous company midpoint | $13.550 million | 67.8% of the $20 million annual midpoint rise |
| Increment in expected H2 revenue compared to pre-results outlook | $6.450 million | Represents a 4.8% upward revision |
The pre-results baseline for the second half is calculated by taking the previous $265 million annual midpoint, then subtracting both the actual revenue from Q1 and the earlier midpoint for Q2.
As a result, over two-thirds of the yearly midpoint rise was achieved in Q2. The implied projection for the second half increased by just $6.45 million compared to the baseline before results. This amounts to a mild adjustment.
Contract conversion is significant. IonQ’s remaining performance obligations (RPO) metric covers both funded and unfunded components of confirmed orders. It does not account for contract options that have yet to be exercised by customers.
Needham’s Quinn Bolton stated that “revenue diversity remained strong this quarter.” According to JPMorgan Chase NYSE:JPM analyst Mayur Ramdhani, RPO growth provided greater clarity through early 2027. Most analyst recommendations following the earnings report were positive. Benzinga
| Firm | Analyst | Recommendation | Target | Upside to $44.43 |
|---|---|---|---|---|
| Rosenblatt Securities | John McPeake | Buy | $100 | 125.1% |
| Wedbush | Matt Bryson | Outperform | $75 | 68.8% |
| Cantor Fitzgerald | Troy Jensen | Overweight | $70 | 57.6% |
| Needham | Quinn Bolton | Buy | $65 | 46.3% |
| Benchmark | Gary Mobley | Buy | $60 | 35.0% |
| JPMorgan Chase NYSE:JPM | Mayur Ramdhani | Neutral | $50 | 12.5% |
Of 14 analysts monitored by MarketBeat, there are nine buy ratings, four hold recommendations, and one sell. The consensus price target stands at $69.92, representing an increase of roughly 57% from Friday’s close.
Execution remains crucial for valuation. With a market capitalization of $16.49 billion, IonQ is valued at about 57.9 times its updated revenue midpoint. When $2 billion in pro forma cash is deducted, the cash-adjusted multiple comes to roughly 50.9 times. This figure does not account for other adjustments to the balance sheet.
Even so, IonQ’s revenue remains on a different level compared to D-Wave Quantum NASDAQ:QBTS and Rigetti Computing NASDAQ:RGTI. D-Wave moved its listing to Nasdaq in July. The multiples given below are based on annualizing each firm’s most recent quarterly revenue and do not represent projections.
| Company | Q2 revenue | Year-on-year growth | Market value | Market value / annualized Q2 revenue |
|---|---|---|---|---|
| IonQ NYSE:IONQ | $80.05 million | 287% | $16.49 billion | 51.5 times |
| D-Wave Quantum NASDAQ:QBTS | $3.08 million | No growth | $7.70 billion | 624.9 times |
| Rigetti Computing NASDAQ:RGTI | $5.14 million | 183% | $5.98 billion | 290.8 times |
IonQ does not appear as stretched as its rivals by this basic sales metric. Still, the stock is not inexpensive. A valuation of more than 50 times annualized quarterly revenue relies on continued strong growth and fast contract execution.
SkyWater continues to be the most significant modeling gap. The transaction was finalized on July 31, post quarter-end, and IonQ’s $280 million–$290 million forecast does not factor in the acquired unit. Pro forma cash decreases from $3 billion to around $2 billion. IonQ’s next scheduled conference is August 19, with its investor day set for September 8.
In the upcoming week, market action will indicate if Friday’s advance remains intact. According to the company’s released calendar, there is no prior scheduled presentation. Market participants await any updated guidance for the merged entity.
Additional support came from government contracts last week. A $28 million extension from DARPA funds manufacturing development and 25 atomic clocks. A separate unexercised option worth $30 million could provide an extra 100 units. IonQ is allocating $15 million towards expanding production capacity. The Capella unit secured an NRO radar-imagery contract, with financial terms not revealed.
Risks: Revenue recognition could stay inconsistent for major systems and government deals. Challenges with SkyWater integration, potential technical setbacks, sizable adjusted losses, warrant-driven GAAP volatility and a high share price may undermine recent gains. The extra DARPA option remains uncertain.
IonQ led in revenue for the quarter. Guidance figures set a modest bar for the second half. Sustaining the rally will hinge on the quality of revenue, pace of contract conversions, and a reliable forecast for the merged company.
Related articles: NYSE:IONQ
